Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers ...

Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, ...

Takeda (TSE:4502/NYSE:TAK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the extension of the ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

Last year, Takeda firmly cemented its place in the emerging markets when it acquired Swiss pharma company, Nycomed, for US $13.7bn. According to a recent report, Russia’s pharmaceutical market ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

However, the companies are still pending ... performance against Zasocinitib if/when both products receive regulatory approvals. Takeda Pharmaceutical demonstrated the ongoing results of their ...

The EMA’s Committee for Medicinal Products for Human Use adopted a positive opinion, recommending a change to the terms of the marketing ...

The lawsuit obtained by MySA revealed that the retailers are accusing the pharmaceutical companies of conspiring to delay the release of the generic version of Takeda's heartburn medication ...